Research programme:Wnt signalling pathway inhibitors - Kyowa Hakko KirinAlternative Names: K-756
Latest Information Update: 30 Oct 2013
At a glance
- Originator Kyowa Hakko Kirin
- Class Small molecules
- Mechanism of Action Tankyrase inhibitors; Wnt signalling pathway inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Research Cancer